Balance and Motor Skills in SLD Children

February 19, 2026 updated by: Nurten NAS KIRDAR, Bandırma Onyedi Eylül University

Assessment of Postural Control, Balance and Fine Motor Skills in Children With Specific Learning Disabilities; A Descriptive Cross-Sectional Study

This study aimed to evaluate postural control, balance, and fine motor skills in children followed up with a diagnosis of specific learning disabilities.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The aim of this study is to evaluate postural control, balance, and fine motor skills in specific learning disabilities, a common problem. While various studies have shown impairments in balance and fine motor skills in the literature, no studies were found that evaluated postural control in children with specific learning disabilities. If the results of this study reveal statistically significant impairments in posture control and balance, observing these physical impairments could partially prevent delays in diagnosing specific learning disabilities. Furthermore, adding specific exercises to the rehabilitation program for children with specific learning disabilities can significantly improve their quality of daily life. The investigators hope that the results of this study will contribute to the literature by raising awareness about specific learning disabilities, postural control, balance, and fine motor skills.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
38

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Turkey (Türkiye)
    • Bandırma
      • Balıkesir, Bandırma, Turkey (Türkiye), 10200
        • Bandırma Onyedi Eylul University Faculty of Medicine
        • Contact:
        • Principal Investigator:
          • Nurten Nas Kırdar, Assistant Professor

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

children diagnosed with specific learning disabilities

Description

Inclusion Criteria:

  • Being followed up with a diagnosis of Specific Learning Disability
  • Being between 6-18 years old

Exclusion Criteria:

  • Cognitive dysfunction
  • Uncontrolled psychiatric illness
  • Mental retardation
  • Vision problems
  • Hearing problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
38 children diagnosed with specific learning disabilities
Other: -Seated Postural Control Measure
-The Seated Postural Control Measure will be used to assess postural control. This measurement evaluates both postural abnormalities and determines the effect of sitting on postural control. The highest possible score on the scale is 88 points for upright sitting posture (USP) and 48 points for upper extremity functionality (UEF). A high score on the test represents good postural control.
Other: -Bruininks-Oseretsky Motor Proficiency Test (two sub-items) for balance
-Balance will be assessed using two sub-items from the short form of the Bruininks-Oseretsky Motor Competency Test. The first test assesses standing on a balance beam with the dominant foot (eyes open), and the second test assesses standing in a "toe-heel contact" position on the balance beam. The time the child spends standing is recorded in seconds. A longer duration indicates better balance.
Other: -Jebsen Taylor Hand Function Test (JTEFT) and 9-Hole Peg Test to assess hand function
-The Jebsen Taylor Hand Function Test (JTHFT) assesses card flipping, picking up small objects, inserting chips, and eating. In the 9-hole peg test, children are asked to place nine pegs one by one into holes on a platform and then remove them. The time elapsed is recorded in seconds. Longer times indicate poor fine motor skills.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Seated Postural Control Measure results
Time Frame: 6 months
-Seated Postural Control Measure results (this measurement described at material metod section)
6 months
Jebsen Taylor Hand Function Test (JTHFT) duration
Time Frame: 6 months
-Jebsen Taylor Hand Function Test (JTHFT) duration
6 months
9-hole peg test duration
Time Frame: 6 months
9-hole peg test duration
6 months
Standing time on the balance board with the dominant foot (Eyes open)
Time Frame: 6 months
This test is a sub-item included in the short form of the Bruininks-Oseretsky Motor Proficiency Test. This test is based on the time it takes to perform the required motor skill in the required manner. The child attempts to stand on a balance beam with their dominant foot, while keeping the other foot in a flexed position parallel to the ground. The child looks at a point 7 feet (2.14 m) away and at eye level, and tries to maintain their balance for 10 seconds. The time they can hold the balance is recorded.
6 months
Standing time in the "toe-heel contact" position on the balance board
Time Frame: 6 months
This test is a sub-item included in the short form of the Bruininks-Oseretsky Motor Proficiency Test. Children are asked to stand on a balance beam for 10 seconds with their back big toe touching the heel of their front foot. The time they can hold the balance is recorded.
6 months

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Relationship between age and Sitting Posture Control Measurement
Time Frame: 6 months
-Relationship between age and Sitting Posture Control Measurement
6 months
Relationship between gender and Sitting Posture Control Measurement
Time Frame: 6 months
-Relationship between gender and Sitting Posture Control Measurement
6 months
Relationship between age and two sub-items of the balance test in the short form of the Bruininks-Oseretsky Motor Proficiency Test
Time Frame: 6 months
-Relationship between age and two sub-items of the balance test in the short form of the Bruininks-Oseretsky Motor Proficiency Test
6 months
Relationship between gender and two sub-items of the balance test in the short form of the Bruininks-Oseretsky Motor Proficiency Test
Time Frame: 6 months
-Relationship between gender and two sub-items of the balance test in the short form of the Bruininks-Oseretsky Motor Proficiency Test
6 months
Relationship between age and Jebsen Taylor Hand Function Test (JTHFT) duration
Time Frame: 6 months
-Relationship between age and Jebsen Taylor Hand Function Test (JTHFT) duration
6 months
Relationship between age and 9-hole peg test duration
Time Frame: 6 months
-Relationship between age and 9-hole peg test duration
6 months
Relationship between gender and Jebsen Taylor Hand Function Test (JTHFT) duration
Time Frame: 6 months
-Relationship between gender and Jebsen Taylor Hand Function Test (JTHFT) duration
6 months
Relationship between gender and 9-hole peg test duration
Time Frame: 6 months
-Relationship between gender and 9-hole peg test duration
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Bandırma Onyedi Eylül University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
February 9, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
August 9, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
August 30, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 2, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 11, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
February 19, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
February 23, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 19, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • E-67961857-050.04-2500033434

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Once our study is completed, and if it is deemed suitable for publication after peer review, all researchers will have access to our results.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Learning Disabilities

Clinical Trials on -Seated Postural Control Measure

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings